- Home
- ORKA vs BBDC Comparison
ORKA vs BBDC Comparison
Compare ORKA & BBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKA
- BBDC
- Stock Information
- Founded
- ORKA 2004
- BBDC 2006
- Country
- ORKA United States
- BBDC United States
- Employees
- ORKA N/A
- BBDC N/A
- Industry
- ORKA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BBDC Diversified Financial Services
- Sector
- ORKA Health Care
- BBDC Finance
- Exchange
- ORKA Nasdaq
- BBDC Nasdaq
- Market Cap
- ORKA 1.0B
- BBDC 1.0B
- IPO Year
- ORKA N/A
- BBDC 2007
- Fundamental
- Price
- ORKA $19.97
- BBDC $9.68
- Analyst Decision
- ORKA Strong Buy
- BBDC Hold
- Analyst Count
- ORKA 6
- BBDC 2
- Target Price
- ORKA $43.60
- BBDC $10.00
- AVG Volume (30 Days)
- ORKA 394.7K
- BBDC 564.0K
- Earning Date
- ORKA 02-15-2025
- BBDC 02-20-2025
- Dividend Yield
- ORKA N/A
- BBDC 10.76%
- EPS Growth
- ORKA N/A
- BBDC 20.95
- EPS
- ORKA N/A
- BBDC 1.09
- Revenue
- ORKA N/A
- BBDC $291,393,000.00
- Revenue This Year
- ORKA N/A
- BBDC $0.43
- Revenue Next Year
- ORKA N/A
- BBDC N/A
- P/E Ratio
- ORKA N/A
- BBDC $8.89
- Revenue Growth
- ORKA N/A
- BBDC 5.26
- 52 Week Low
- ORKA $17.64
- BBDC $8.67
- 52 Week High
- ORKA $53.88
- BBDC $10.38
- Technical
- Relative Strength Index (RSI)
- ORKA N/A
- BBDC 50.92
- Support Level
- ORKA N/A
- BBDC $9.41
- Resistance Level
- ORKA N/A
- BBDC $9.48
- Average True Range (ATR)
- ORKA 0.00
- BBDC 0.15
- MACD
- ORKA 0.00
- BBDC 0.02
- Stochastic Oscillator
- ORKA 0.00
- BBDC 75.00
About ORKA Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis.
About BBDC Barings BDC Inc.
Barings BDC Inc operates as a closed-end, non-diversified investment company and has elected to be treated as a business development company. The company's investment objective is to generate current income by investing directly in privately held middle-market companies to help these companies fund acquisitions, growth, or refinancing. Barings employs fundamental credit analysis and targets investments in businesses with low levels of cyclicality and operating risk relative to other businesses in this market segment. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility.